(Society for Academic Emergency Medicine) The 'own-point-of-view' perspective video technique, coupled with a subjective re situ interview, provides a better understanding of how physicians make clinical decisions in an authentic treatment setting, compared with the conventional external perspective.
Medical society calls for legal changes, saying spiralling £1.5bn annual bill diverts significant funding from frontline care The annual cost to the NHS in England of settling clinical negligence claims is equivalent to training 6,500 doctors and is expected to double by 2023, according to the Medical Protection Society. Show More Summary
(European Society of Cardiology) The press schedule for ESC Congress 2017 is announced today. Journalists are invited to attend 6 hot line session press conferences including a Clinical Trial Update and a Late Breaking Registry Results...Show More Summary
(The Endocrine Society) Type 2 diabetes (T2D) and osteoporosis often coexist in patients, but managing both conditions can be a challenge. A comprehensive review published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism highlights the most effective treatment options for treating these conditions together.
(Society for Neuroscience) A clinically available anxiety drug safely and effectively protects against brain defects caused by the mouse version of a common human virus, finds new research published in The Journal of Neuroscience.
(American Society for Radiation Oncology) The American Society for Radiation Oncology (ASTRO) issued a new clinical guideline for the use of stereotactic body radiation therapy (SBRT) in early-stage lung cancer today.
Loyola Medicine pathologist Kamran Mirza, MD, PhD, FASCP, has been named to the American Society for Clinical Pathology's prestigious "40 Under Forty" list of future leaders in the field.
An experimental immunotherapy treatment for multiple myeloma from a biotech company in China captured wide attention at the just-concluded American Society of Clinical Oncology (ASCO) meeting. We’ve been following news reports from the meeting closely since it kicked off last Friday: High drug costs (and stock values) take center stage at final day of ASCO […]
For the past few days we’ve been keeping a close eye on the news coverage coming out of the annual meeting of the American Society of Clinical Oncology (ASCO), the world’s largest cancer research conference: Small studies get big headlines at ASCO 2017 6 things to keep in mind if you read cancer-related news in […]
At the 2017 annual meeting of the American Society of Clinical Oncology (ASOC) women heard some reassuring news about the long-term results of a breast cancer study. That comforting news? It appears to be safe for women to get pregnant following an early stage breast cancer diagnosis. The post Study: Pregnancy After Breast Cancer Is Safe appeared first on Growing Your Baby.
(University of Colorado Anschutz Medical Campus) Clinical trial results presented in an oral abstract session 3:00pm Monday, June 5 at the American Society for Clinical Oncology (ASCO) Annual Meeting 2017 shows promising results forShow More Summary
Nearly 40,000 cancer specialists have converged in Chicago for the world’s largest cancer meeting. The American Society of Clinical Oncology (ASCO) meeting — which began last Friday and runs through tomorrow — traditionally draws international media attention. As our deputy managing editor, Joy Victory, reported last week, it has become a perennial exercise in spotting […]
(American Society of Clinical Oncology) Malignant pleural mesothelioma or MPM is a rare cancer, but its incidence has been rising. This cancer is usually associated with asbestos exposure, and patients have a median life expectancy of only 13-15 months. Show More Summary
(American Society of Clinical Oncology) A phase III clinical trial of 4,805 women with HER2-positive breast cancer suggests adding a second HER2 targeted medicine, pertuzumab (Perjeta), to standard of care trastuzumab (Herceptin) after surgery may help, although the benefit is modest.
(American Society of Clinical Oncology) Findings from a phase III clinical trial point to a more effective initial treatment for patients with ALK-positive non-small cell lung cancer (NSCLC). Compared to the current standard of careShow More Summary
(American Society of Clinical Oncology) In an early clinical trial, 33 out of 35 (94 percent) patients had clinical remission of multiple myeloma upon receiving a new type of immunotherapy -- chimeric antigen receptor (CAR) T cells targeting B-cell maturation protein or BCMA. Most patients had only mild side effects.
(American Society of Clinical Oncology) Findings from a phase III clinical trial point to a potential new treatment for patients newly diagnosed with advanced, epidermal growth factor receptor (EGFR)-positive non-small cell lung cancer (NSCLC). Show More Summary
(American Society of Clinical Oncology) Scientists may have developed the first targeted, oral, tumor-type agnostic therapy -- a cancer medicine that works comparably well across many kinds of cancer, regardless of patient age. In clinical...Show More Summary
(American Society of Clinical Oncology) Findings from a retrospective study of 1,200 women provide reassurance to breast cancer survivors who are contemplating pregnancy. In the study, women who became pregnant after an early breastShow More Summary
(University of Colorado Anschutz Medical Campus) A study presented today at the American Society for Clinical Oncology (ASCO) Annual Meeting 2017 shows only 9 percent of 259 evaluated AML patients received all seven of the NCCN-recommended genetic tests.